Compass Pathways (MEX:CMPSN) Volatility: 71.60% (As of Jun. 26, 2026)


MEX:CMPSN Compass Pathways PLC MEX:CMPSN
14 GF Score
Price MXN242.00
! 2 Warning Signs
View Full Analysis

What is Compass Pathways Volatility?

Compass Pathways MEX:CMPSN 14 Volatility is 71.60% as of Jun. 26, 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-26), Compass Pathways's Volatility is 71.60%.

Compass Pathways  (MEX:CMPSN) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Compass Pathways Volatility Related Terms

MEX:CMPSN vs MD, SGRY, ADUS: Volatility Comparison

For the Medical Care Facilities subindustry, Compass Pathways's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compass Pathways Volatility vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Volatility distribution charts can be found below:

* The bar in red indicates where Compass Pathways's Volatility falls into.


MEX:CMPSN
14GF Score
Compass Pathways PLC MEX:CMPSN
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways  (MEX:CMPSN) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 71.60% mean?
Compass Pathways (MEX:CMPSN) has a Volatility of 71.60% as of Jun. 26, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Compass Pathways and its competitors.
Is Compass Pathways' Volatility too high?
Compass Pathways' current Volatility is 71.60%. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Volatility compare to MD and SGRY?
Compass Pathways' Volatility of 71.60% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Healthcare Providers & Services company?
A good Volatility depends on the Healthcare Providers & Services industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Compass Pathways and its competitors. Compass Pathways's current Volatility is 71.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Volatility of 71.60%. The current Volatility is 71.60%. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Volatility is 71.60% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Compass Pathways Business Description

Other Exchanges CMPS:USA5Y6:Germany
Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score

Get the complete analysis for MEX:CMPSN

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN242.00
Price